Next-generation drug from Eli Lilly boosts weight loss to 24% ... - CNN
2023年6月26日 · An experimental drug from Eli Lilly helped patients with obesity lose an average of 24% of their body weight over 48 weeks on the highest dose in a mid-stage study, the most weight loss seen...
Lilly launches lower-price weight loss drug without injector pen - CNN
2024年8月27日 · Starter doses of the weight-loss drug Zepbound are now available in single-dose vials, drug manufacturer Eli Lilly announced Tuesday, a move the company says will “significantly” expand supply...
FDA approves Eli Lilly’s Zepbound, a weight loss drug similar to ...
2023年11月8日 · The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to help people lose up to 52 pounds in...
What to know about Zepbound, Eli Lilly’s new weight loss drug - NBC News
2023年11月9日 · Zepbound belongs to a new class of medications, alongside Ozempic and Wegovy, that have skyrocketed in popularity in the U.S. A new weight loss drug has been approved that promises to be the...
FDA Approves New Medication for Chronic Weight Management
Today, the U.S. Food and Drug Administration approved Zepbound (tirzepatide) injection for chronic weight management in adults with obesity (body mass index of 30 kilograms per square meter (kg...
FDA Approves New Drug Treatment for Chronic Weight …
FDA approves Wegovy (semaglutide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition.
What the results of Wegovy’s longest clinical trial yet show about ...
2024年5月13日 · New analyses of the longest clinical trial yet of the weight-loss drug Wegovy are shedding light on how quickly it helps people lose weight, how long they sustain that weight loss and how...
FDA approves Zepbound, new Wegovy rival : Shots - Health News : NPR
2023年11月8日 · Eli Lilly & Co., maker of Zepbound, says it shows greater weight loss at a lower list price than Wegovy. The Lilly drug will be available in the U.S. by the end of the year. A version of the...
Questions and answers about the new anti-obesity medications
2024年1月1日 · Studies confirmed this effect, and the FDA eventually approved the medications for weight loss, under new brand names: Wegovy, Saxenda, and Zepbound. For overweight or obesity, the drugs are typically prescribed in higher doses than their diabetes counterparts.
What to Know About Zepbound, the New Weight Loss Drug - The New York Times
2023年11月8日 · Zepbound is the second drug in a new class of obesity medications to be approved for weight loss, following Wegovy. And it is now likely the most effective treatment to combat obesity besides...